New Zealand - English - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - bisacodyl 5mg - enteric coated tablet - 5 mg - active: bisacodyl 5mg excipient: carnauba wax hyprolose hypromellose methacrylic acid copolymer eudragit l 100 iron oxide yellow isopropyl alcohol lactose monohydrate magnesium stearate   methacrylic acid copolymer microcrystalline cellulose purified talc purified water   starch sucrose titanium dioxide triethyl citrate - short term relief of constipation

New Zealand - English - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - opium tincture 1.369%{relative} ((=1.608%w/v) = 0.0165%w/v anhydrous morphine);  ; squill oxymel 3.78%{relative} (as sfm oxymel squill 125:1000 = 1.67%w/v squill) - linctus - active: opium tincture 1.369%{relative} ((=1.608%w/v) = 0.0165%w/v anhydrous morphine)   squill oxymel 3.78%{relative} (as sfm oxymel squill 125:1000 = 1.67%w/v squill) excipient: benzoic acid camphor ethanol honey methyl hydroxybenzoate purified water star anise oil sugar premium liquid tolu syrup - relief from wet, productive and irritating cough (label claim).

New Zealand - English - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - opium tincture 1.369%{relative} (1% as 1.608%w/v = anhydrous morphine 0.0165%w/v);  ; squill oxymel 3.78%{relative} (sfm squill oxymel bp 125:1000 =squill 1.67%w/v) - linctus - active: opium tincture 1.369%{relative} (1% as 1.608%w/v = anhydrous morphine 0.0165%w/v)   squill oxymel 3.78%{relative} (sfm squill oxymel bp 125:1000 =squill 1.67%w/v) excipient: benzoic acid camphor ethanol honey methyl hydroxybenzoate purified water star anise oil sugar premium liquid tolu syrup - demulcent expectorant and cough suppressant (label claim).

New Zealand - English - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - pseudoephedrine hydrochloride 60mg;  ;  ;   - tablet - 60 mg - active: pseudoephedrine hydrochloride 60mg       excipient: lactose monohydrate magnesium stearate maize starch

New Zealand - English - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - domperidone maleate 12.72mg equivalent to domperidone 10 mg - tablet - 10 mg - active: domperidone maleate 12.72mg equivalent to domperidone 10 mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate maize starch microcrystalline cellulose povidone purified water sodium laurilsulfate - treatment of acute symptoms of nausea and vomiting.

New Zealand - English - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - finasteride 1mg - film coated tablet - 1 mg - active: finasteride 1mg excipient: docusate sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry brown 03a86790 pregelatinised maize starch purified water sodium starch glycolate - pharmacare finasteride 1 mg film coated tablets: finasteride is indicated for the treatment of men with male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss. finasteride is not indicated for use in women (see warnings and precautions, pregnancy) or children. finasteride is not effective in postmenopausal women with androgenetic alopecia.

New Zealand - English - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - citalopram hydrobromide 24.99mg equivalent to citalopram 20 mg;  ;   - film coated tablet - 20 mg - active: citalopram hydrobromide 24.99mg equivalent to citalopram 20 mg     excipient: croscarmellose sodium hypromellose lactose monohydrate macrogol 400 magnesium stearate maize starch microcrystalline cellulose purified talc purified water titanium dioxide - treatment of depressive illness in the initial phase and as maintenance against potential relapse or recurrence.

New Zealand - English - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - sodium bicarbonate 100% - powder for oral solution - 100 % - active: sodium bicarbonate 100%

New Zealand - English - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - atorvastatin calcium trihydrate 10.825mg equivalent to atorvastatin 10 mg - film coated tablet - 10 mg - active: atorvastatin calcium trihydrate 10.825mg equivalent to atorvastatin 10 mg excipient: butylated hydroxyanisole colloidal silicon dioxide croscarmellose sodium sepifilm lp 010 magnesium stearate mannitol microcrystalline cellulose purified water sodium carbonate sodium laurilsulfate - indicated as an adjunct to diet to reduce elevated total-c, ldl-c and tg levels in patients with primary hypercholesterolaemia or mixed dyslipidaemia where the primary abnormality is either elevated cholesterol or triglycerides when response to diet and other non-pharmacological measures is inadequate. atorvastatin tablet is also indicated to reduce total-c and ldl-c in patients with heterozygous and homozygous familial hypercholesterolaemia.

New Zealand - English - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - atorvastatin calcium trihydrate 21.65mg equivalent to atorvastatin 20 mg - film coated tablet - 20 mg - active: atorvastatin calcium trihydrate 21.65mg equivalent to atorvastatin 20 mg excipient: butylated hydroxyanisole colloidal silicon dioxide croscarmellose sodium sepifilm lp 010 magnesium stearate mannitol microcrystalline cellulose purified water sodium carbonate sodium laurilsulfate - indicated as an adjunct to diet to reduce elevated total-c, ldl-c and tg levels in patients with primary hypercholesterolaemia or mixed dyslipidaemia where the primary abnormality is either elevated cholesterol or triglycerides when response to diet and other non-pharmacological measures is inadequate. atorvastatin tablet is also indicated to reduce total-c and ldl-c in patients with heterozygous and homozygous familial hypercholesterolaemia.